Dr. Amol Dongre

Senor Oncologist

Trained at: Tata Memorial Hospital, Mumbai

Qualifications:

DM - Medical Oncology

Expertise:

Thoracic Cancer ,

Gastrointestinal Cancer ,

Gynecological Cancer ,

Hematologic Cancer ,

Breast Cancer ,

Paediatric Cancers

Practicing at:

Alexis Multispeciality Hospital, Nagpur

Experience:

18 Years


Organ Specialization


Publications

  • • Oral Presentation and Best Paper Award in Mumbai Hematology Group organized annual conference in Tata Memorial Hospital Nov – 2009, India Amol Dongre, Brijesh Arora, P Kurkure, S D Banavali. “ Low-dose GCSF prophylaxis is as effective as standard-dose in Paediatric cancer patients receiving myelosuppressive chemotherapy A prospective randomized open labelled parallel group phase III study
  • • Oral Presentation in PHOCON 2009 (Annual conference of Pediatric Hemato-Oncology association of India) Chandigarh Dec- 2009, India. Amol Dongre, Seema Gulia, Brijesh Arora, Shripad Banavali. “Posterior Reversible Encephalopathy Syndrome in Paediatric cancer patients” • Amol Dongre, Brijesh Arora, Gaurav Narula, S.D Banavali. Clinico-Biologic profile and outcome of Langerhans cell histiocytosis: A large experience from Tata Memorial Hospital” Boston SIOP Oct 2010 (Paediatric Blood and Cancer- official journal of SIOP)
  • • Amol Dongre, Brijesh Arora, Seema Medhi, S.D Banavali. “Clinico-Radiologic profile and outcome in Paediatric cancer patients with Posterior Reversible Encephalopathy Syndrome (PRES): A single Institutional study” (Paediatric Blood and Cancer- official journal of SIOP)Boston SIOP Oct 2010
  • • Oral Presentation and Best Paper Award in PHOCON 2010 (Annual conference of Pediatric Hemato-Oncology association of India),in Nagpur, Dec- 2010. Amol Dongre, Sondhi V, Brijesh Arora, S.D Banavali “Risk factors, outcome predictors and response to antifungals in leukemic children with invasive fungal infections- A large experience from India
  • • Amol Dongre, Brijesh Arora, Seema Medhi, Tushar Vora, Ajay Puri S.D Banavali. Improved outcome in extremity non-metastatic ewings sarcoma by intensified continuous multiagent chemotherapy: Analysis of 159 patients from Tata memorial hospital, India” (Poster presentation) Auckland SIOP Oct 2011
  • • Amol Dongre, Ravi T, Gaurav G, S Kannan, B Bagal, J Gawande, R Nair, N Khattry. “Results of hematopoietic stem cell transplantation in patients with aplastic anemia from Tata Memorial Center, Mumbai.” (Poster presentation) Indian Society of Hematology & Transfusion Medicine. PGIMER Chandigarh, Nov 2011 India.Indian J Hematol Blood Transfus 2011; 27(4):185-289.
  • • Amol Dongre, Randip Singh, Ravi Tippeswamy, Sadhana Kannan, Reena Nair, Navin Khattry, Results of autologous transplants for children from a tertiary cancer center in India. J Clin Oncol 30:15s, 2012 (suppl; abstr 9559).
  • • Bagal B, Amol Dongre, H. Menon, R. Nair, M. Sengar, Navin Khattry. Outcomes of autologous stem cell transplant (ASCT) in multiple myeloma from a tertiary cancer centre in India. J Clin Oncol 30:15s, 2012 (suppl; abstr).
  • • Amol Dongre, Dwivedi P, Brijesh Arora, S.D.Banavali. Oral presentation in 12th International conference on malignant Lymphomas (ICML), Lugano, Switzerland 2013.Clinical presentation and outcome of advanced stage hodgkins lymphoma in children: A retrospective study
  • • Amol Dongre, Dwivedi P, Brijesh Arora, S.D.Banavali. Validation of CHIP score in patients with advanced stage hodgkins lymphoma (Poster presentation) SIOP 2013; Hong-Kong Original articles accepted for publication:
  • • "Is there a limitation of RECIST (Response evaluation criteria in solid tumours) criteria in prediction of pathological response, in Head and neck cancers, post induction chemotherapy? A preliminary report," by Vijay Patil, Vanita Noronha, Amit Joshi, Vamshi Muddu Krishna, Shashikant Juvekar, Gouri Pantvaidya, Pankaj Chaturvedi, Devendra Chaukar, Supreeta Arya, Asawari Patil, Bharatsingh Bhosale, Amol Dongre, A. K. D'cruz and Kumar Prabhash
  • • The changing landscape of hormonal therapy in castration- resistant prostate cancer. Amol Dongre, Kumar Prabhash, Vanita Noronha. South Asian Journal of Cancer. 01/2012; 1(2):53-55 Book Chapters
  • • Amol Dongre, B. Arora, “Management of Pediatric Anaplastic large cell lymphoma” EBM 2010. Chapter 17, pages 205-217
  • • Amol Dongre,. “Prognostic factors in early and advanced stage Hodgkin’s lymphoma” EBM 2012 Chapter 3, pages 26-39
  • • Amol Dongre, A.Nahar, “Management of Standard risk and High Risk ALL in children” EBM 2010. EBM 2011 Chapter 3 , pages 47-70
  • • Amol Dongre, S.Gulia, B. Arora, S. D. Banavali. “Acute lymphoblastic leukemia: Therapeutic strategies – Newer horizons”. Hematology Today –Jan 2010. Chapter 1, pages 1-14
  • • S. Gulia, A. Dongre, B .Arora, S. D. Banavali. “Acute promyelocytic leukemia in children: current management”. Hematology Today – Jan 2010 Chapter 8, pages 67-76
  • • Amol Dongre, Brijesh Arora "Langerhans Cell Histiocytosis: Current Concepts and Controversies" for Hematology Today-Jan 2011

Honours and Awards

  • • Oral Presentation and Best Paper Award in Mumbai Hematology Group organized annual conference in Tata Memorial Hospital Nov – 2009, India
  • • Oral Presentation and Best Paper Award in PHOCON 2010 (Annual conference of Paediatric Hemato-Oncology association of India), Nagpur, Dec- 2010.
  • • Clinical Research fellowship (ACORD 2012) Australia sept-2012
  • • American Association for Clinical Research (AACR) fellowship Vail, Colarado july 2013
  • • Full Scholarship for Poster Presentation in SIOP-2013 in Hong-Kong
  • • Oral Presentation and Best Paper Award in HAEMATOCON, Nov 2013 Mumbai, India.
  • • International Development & Efficiency Award, March 2014
  • • Young Achiever Award at NAGPUR ENTREPRENEUR & EXCELLENCE AWARDS, 2017 today organised by 94.3 MY FM , March 2017
  • • Young Achiever Award by Academy of Medical Sciences, Feb 2019

Registration

  • 2004020677 Maharashtra Medical Council

Education

  • MBBS(IGMCH-2002)
  • MD(PEDIATRICS-2007-PGIMER UNIVERSITY)
  • DM(MEDICAL OMCOLOGY-TATA MEMOIAL CENTRE MUMBAI-2013)

Frequently asked questions

Where can I meet Dr. Amol Dongre for consultation?

Dr. Amol Dongre visits Alexis Multispeciality Hospital , Nagpur. The doctor also provides teleconsultation via Onco.com. You can call for this service.

How can I get an appointment with Dr. Amol Dongre?

You can book a priority appointment with Dr. Amol Dongre through us. Request a call back or call us on .

What is Dr. Amol Dongre’s speciality?

Dr. Amol Dongre specialises in medical oncology for thoracic cancer, gastrointestinal cancer, gynecological cancer, hematologic cancer, breast cancer, paediatric cancers.

What medical qualification does Dr. Amol Dongre have?

Dr. Amol Dongre’s medical qualification is DM - Medical Oncology. You can also book an appointment with Dr. Amol Dongre on Onco.com

How many years of experience does Dr. Amol Dongre have?

Dr. Amol Dongre has 18 years of experience in the field of medical oncology for thoracic cancer, gastrointestinal cancer, gynecological cancer, hematologic cancer, breast cancer, paediatric cancers.

How much does Dr. Amol Dongre charge for consultation?

To know more accurate consultation fees, please get in touch with us.

Why should patients or care givers visit Dr. Amol Dongre?

Patients or Care givers often visit Dr. Amol Dongre for thoracic cancer, gastrointestinal cancer, gynecological cancer, hematologic cancer, breast cancer, paediatric cancers. To get more information on reasons to visit Dr. Amol Dongre, please visit Dr. Amol Dongre profile on Onco.com


Videos by experts

Feel like talking?

Write to us

help@onco.com